Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 05, 2020 03:00 ET | Source: Cryogenic Industries

Nikkiso Cryogenic Industries Group Expands in Russia and Wins Project for LNG Liquefaction Terminal

TEMECULA, Calif., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Nikkiso Cryogenic Industries’ Clean Energy & Industrial Gases Group (“Group”), a subsidiary of Nikkiso Co., Ltd (Japan), announces the...
September 23, 2019 09:35 ET | Source: CryptoCurrencyWire

CryptoCurrencyWire Announces Collaboration with Blockchain Life 2019 as the Official Newswire

MOSCOW, Sept. 23, 2019 (GLOBE NEWSWIRE) -- via CryptoCurrencyWire – CryptoCurrencyWire (“CCW”), a multifaceted financial news and publishing company, announces its partnership with Blockchain Life...
September 21, 2016 11:00 ET | Source: Vantage LED

Vantage LED Salesman Rows for Team USA

ATLANTA, GA--(Marketwired - September 21, 2016) - With over fifteen years of international sales and marketing experience, David Bittenbender has been an integral leader of the Vantage LED sales force...
July 30, 2014 14:40 ET | Source: Rafarma Pharmaceuticals, Inc.

Rafarma Pharmaceuticals (RAFA) Announces New President as Part of Pending Acquisition of Majority Interest

MOSCOW, July 30, 2014 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals Inc. (Pink Sheets:RAFA) announces the appointment of Mr. Bruno Horn, a Swiss citizen, as the new President and Director of the...
May 12, 2014 09:15 ET | Source: Rafarma Pharmaceuticals, Inc.

Rafarma Pharmaceuticals (RAFA) Commences Preparation of Audited Financials

MOSCOW, May 12, 2014 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. (Pink Sheets:RAFA) has commenced a formal audit to provide additional transparency in its public filings with a forward view to...
June 06, 2013 09:18 ET | Source: Rafarma Pharmaceuticals, Inc.

Rafarma (RAFA) Enters $50,000,000 Ceftriaxone Market and Signs Long-Term National and Regional Distribution Contracts

SANDY, Utah, June 6, 2013 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. (the "Company") (Pink Sheets:RAFA) announces commencement of production of the antibiotic Ceftriaxone. Ceftriaxone treats...